LAVAL, QC, Feb. 2, 2021 /CNW/ -- Bausch Health Companies
Inc. (NYSE/TSX: BHC) ("Bausch Health") and its dermatology
business, Ortho Dermatologics, one of the largest prescription
dermatology health care businesses, today announced the opening of
the application process for its 2021 Aspire Higher scholarship
program. The program, which began in 2013, will award nine students
who have been treated for a dermatologic condition with a
scholarship of up to $10,000 in
support of their academic goals.
"Many students today are balancing a mix of in-person and remote
education in addition to managing part-time jobs and
extra-curricular activities. In normal circumstances, it can be
challenging for students to juggle all that is part of getting an
education, and with the added physical and emotional burden of
living with a skin condition during a worldwide pandemic, it's even
more difficult," said Scott Hirsch,
senior vice president and chief strategy officer, Bausch Health,
and president, Ortho Dermatologics. "We are excited to continue the
Aspire Higher scholarship program in 2021 and to assist deserving
students as they work to achieve their academic goals."
To apply for the 2021 scholarship, students are required to
submit letters of recommendation along with a long-form essay
describing the impact of their dermatologic condition and the role
that a dermatologist, physician assistant or nurse practitioner has
played in helping to treat their condition. Scholarships are open
to applicants who have been accepted to, or students currently
attending, an accredited, nonprofit, two- or four-year college,
university or advanced (post-high school) vocational or technical
school for the 2021-2022 academic year.
Scholarships are available in the following three
categories:
- Undergraduate Scholar Awards for students pursuing
undergraduate degrees
- Graduate Scholar Awards for students pursuing
graduate degrees
- Today's Woman Scholar Awards for students who are
mothers pursuing either undergraduate or graduate degrees
"For several years, I've tackled a chronic skin disease while
fighting to accept myself with this condition," said Magdalena Augustine, a 2020 Aspire Higher
scholarship recipient. "The Aspire Higher Scholarship Program has
made that fight so much easier by recognizing students like me who
are living with skin conditions and helping to support our higher
education aspirations."
Students can apply for the Aspire Higher scholarship through
May 31, 2021, and winners will be
announced in July 2021. To learn more
about the scholarship, including eligibility criteria, terms and
conditions, and to see stories from previous winners, please visit
www.AspireHigherScholarships.com.
About Aspire Higher
Since 2013, the Aspire Higher
scholarship program has awarded 51 scholarships, providing students
a total of $738,000 toward their
higher education on campuses nationwide. The Aspire Higher
Scholarship program is funded through the Bausch Foundation.
About the Bausch Foundation
The Bausch Foundation was
established in 2017 to improve the lives of patients globally by
providing access to safe, effective medicines and by financially
supporting health care education and causes. Since its
inception, the Bausch Foundation has contributed millions of
dollars' worth of financial and product donations to charitable
health organizations.
About Ortho Dermatologics
Ortho Dermatologics is one of the largest dermatology businesses
dedicated to helping patients in the treatment of a range of
therapeutic areas, including psoriasis, actinic keratosis, acne,
atopic dermatitis and other dermatoses. The Ortho Dermatologics
portfolio is further complemented by Solta Medical, the maker of
Fraxel®, Thermage®, Clear + Brilliant® and Vaser® ultrasonic
assisted liposuction for aesthetic applications. More information
can be found at www.ortho-dermatologics.com.
About Bausch Health
Bausch Health Companies Inc.
(NYSE/TSX: BHC) is a global company whose mission is to improve
people's lives with our health care products. We develop,
manufacture and market a range of pharmaceutical, medical device
and over-the-counter products, primarily in the therapeutic areas
of eye health, gastroenterology and dermatology. We are delivering
on our commitments as we build an innovative company dedicated to
advancing global health. More information can be found at
www.bauschhealth.com.
Forward-looking Statements
This news release may
contain forward-looking statements, which may generally be
identified by the use of the words "anticipates," "expects,"
"intends," "plans," "should," "could," "would," "may," "believes,"
"estimates," "potential," "target," or "continue" and variations or
similar expressions. These statements are based upon the current
expectations and beliefs of management and are subject to certain
risks and uncertainties that could cause actual results to differ
materially from those described in the forward-looking statements.
These risks and uncertainties include, but are not limited to, the
risks and uncertainties discussed in Bausch Health's most recent
annual report on Form 10-K and detailed from time to time in Bausch
Health's other filings with the U.S. Securities and Exchange
Commission and the Canadian Securities Administrators, which
factors are incorporated herein by reference. They also include,
but are not limited to, risks and uncertainties caused by or
relating to the evolving COVID-19 pandemic, and the fear of that
pandemic and its potential effects, the severity, duration and
future impact of which are highly uncertain and cannot be
predicted, and which may have a material adverse impact on Bausch
Health, including but not limited to its project development
timelines, and costs (which may increase). Readers are cautioned
not to place undue reliance on any of these forward-looking
statements. These forward-looking statements speak only as of the
date hereof. Bausch Health undertakes no obligation to update any
of these forward-looking statements to reflect events or
circumstances after the date of this news release or to reflect
actual outcomes, unless required by law.
®/TM are trademarks of Ortho Dermatologics' affiliated
entities.
© 2021 Ortho Dermatologics' affiliated
entities.
NPR.0022.USA.21
Investor
Contact:
|
Media
Contact:
|
Arthur
Shannon
|
Lainie
Keller
|
arthur.shannon@bauschhealth.com
|
lainie.keller@bauschhealth.com
|
(514)
856-3855
|
(908)
927-1198
|
(877) 281-6642 (toll
free)
|
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/ortho-dermatologics-announces-2021-aspire-higher-scholarship-program-301218590.html
SOURCE Bausch Health Companies Inc.